Frutenor

Frutenor is a pharmaceutical preparation containing Levocarnitine, used for intravenous administration. It supports metabolic function and energy production in the body.

Frutenor, containing Levocarnitine, is primarily used to address carnitine deficiencies. This can occur in various conditions where the body's ability to process fats for energy is impaired. Levocarnitine plays a crucial role in transporting fatty acids into the mitochondria, where they are converted into energy. This makes it useful in managing certain metabolic disorders and supporting overall energy metabolism.

When administered intravenously, Frutenor may help improve energy levels and reduce fatigue. Some users report enhanced physical performance and better metabolic function. However, individual responses can vary, and it is important to monitor for any adverse reactions.

Frutenor should be used under medical supervision, especially for intravenous administration. It is important to follow the prescribed dosage and administration guidelines to avoid potential side effects. Patients with known allergies to Levocarnitine or any of the excipients should avoid using this medication.

Frutenor may interact with certain medications, including those that affect the metabolism of Levocarnitine. It is advisable to consult a healthcare provider before combining Frutenor with other medications. Additionally, alcohol and certain dietary supplements may influence the effectiveness of Levocarnitine.